Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1985 3
1986 1
1987 4
1988 1
1989 3
1992 1
1994 1
1996 1
1997 3
1998 5
1999 3
2000 4
2001 7
2002 5
2003 8
2004 8
2005 5
2006 4
2007 9
2008 16
2009 13
2010 14
2011 16
2012 17
2013 15
2014 17
2015 30
2016 18
2017 27
2018 25
2019 24
2020 19
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

302 results
Results by year
Filters applied: . Clear all
Page 1
Obesity and Airway Dysanapsis in Children with and without Asthma.
Forno E, Weiner DJ, Mullen J, Sawicki G, Kurland G, Han YY, Cloutier MM, Canino G, Weiss ST, Litonjua AA, Celedón JC. Forno E, et al. Among authors: sawicki g. Am J Respir Crit Care Med. 2017 Feb 1;195(3):314-323. doi: 10.1164/rccm.201605-1039OC. Am J Respir Crit Care Med. 2017. PMID: 27552676 Free PMC article.
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.
Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS. Konstan MW, et al. Among authors: sawicki gs. Lancet Respir Med. 2017 Feb;5(2):107-118. doi: 10.1016/S2213-2600(16)30427-1. Epub 2016 Dec 21. Lancet Respir Med. 2017. PMID: 28011037 Clinical Trial.
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis.
Walker S, Flume P, McNamara J, Solomon M, Chilvers M, Chmiel J, Harris RS, Haseltine E, Stiles D, Li C, Ahluwalia N, Zhou H, Owen CA, Sawicki G; VX15-661-113 Investigator Group. Walker S, et al. Among authors: sawicki g. J Cyst Fibros. 2019 Sep;18(5):708-713. doi: 10.1016/j.jcf.2019.06.009. Epub 2019 Jun 26. J Cyst Fibros. 2019. PMID: 31253540 Free article. Clinical Trial.
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS. McNamara JJ, et al. Among authors: sawicki gs. Lancet Respir Med. 2019 Apr;7(4):325-335. doi: 10.1016/S2213-2600(18)30460-0. Epub 2019 Jan 24. Lancet Respir Med. 2019. PMID: 30686767 Clinical Trial.
Pharmacological Protection of Kidney Grafts from Cold Perfusion-Induced Injury.
Krzywonos-Zawadzka A, Franczak A, Moser MAJ, Olejnik A, Sawicki G, Bil-Lula I. Krzywonos-Zawadzka A, et al. Among authors: sawicki g. Biomed Res Int. 2019 May 14;2019:9617087. doi: 10.1155/2019/9617087. eCollection 2019. Biomed Res Int. 2019. PMID: 31218229 Free PMC article. Review.
302 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page